Literature DB >> 138556

Acne: treatment with minocycline.

R J Coskey.   

Abstract

Forty-seven patients with acne, unresponsive to tetracycline and erythromycin, were treated with 100 mg minocycline daily. About one-quarter showed a 50% improvement or better. Five patients became dizzy during the first week of therapy, making it necessary to stop the medication in four instances. Two patients stopped treatment after several months because of esophagitis in one and headaches in another. Vestibular side effects are the most common complication of treatment. Patients should be warned about this side effect and if it occurs should avoid driving or handling machines. In some instances, dizziness may be so severe that the drug will have to be discontinued.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 138556

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  3 in total

Review 1.  Minocycline for acne vulgaris: efficacy and safety.

Authors:  Sarah E Garner; Anne Eady; Cathy Bennett; John Norman Newton; Karen Thomas; Catalin Mihai Popescu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

2.  Minocycline development for acute ischemic stroke.

Authors:  Susan C Fagan; Lydia E Cronic; David C Hess
Journal:  Transl Stroke Res       Date:  2011-06-01       Impact factor: 6.829

Review 3.  Minocycline for short-term neuroprotection.

Authors:  Hazem F Elewa; Hend Hilali; David C Hess; Livia S Machado; Susan C Fagan
Journal:  Pharmacotherapy       Date:  2006-04       Impact factor: 4.705

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.